5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | NEUTRAL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.22▼ | 2.24▼ | 2.25▼ | 2.27▼ | 2.21▲ |
MA10 | 2.22▼ | 2.25▼ | 2.29▼ | 2.21▼ | 1.29▲ |
MA20 | 2.24▼ | 2.30▼ | 2.36▼ | 2.23▼ | 0.92▲ |
MA50 | 2.26▼ | 2.32▼ | 2.22▼ | 1.11▲ | 0.98▲ |
MA100 | 2.30▼ | 2.21▲ | 2.27▼ | 0.88▲ | 1.40▲ |
MA200 | 2.37▼ | 2.28▼ | 1.79▲ | 0.97▲ | 3.94▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | -0.011▼ | -0.027▼ | -0.061▼ | 0.237▲ |
RSI | 36.953▼ | 39.228▼ | 42.218▼ | 59.815▲ | 70.286▲ |
STOCH | 48.401 | 33.210 | 30.401 | 41.715 | 74.347 |
WILL %R | -81.818▼ | -69.767 | -86.869▼ | -68.478 | -34.200 |
CCI | -43.661 | -124.113▼ | -94.937 | -23.332 | 103.293▲ |
Tuesday, July 29, 2025 06:35 AM
We recently published These 10 Stocks are Winning Big. Vor Biopharma Inc. (NASDAQ:VOR) is one of the best-performing stocks on Monday. Vor Biopharma extended its winning streak to a fourth consecutive ...
|
Tuesday, July 22, 2025 07:53 AM
Key Insights Insiders appear to have a vested interest in Vor Biopharma's growth, as seen by their sizeable ownership ...
|
Saturday, July 19, 2025 09:35 PM
Vor Biopharma Inc. (NASDAQ:VOR) is one of the hot penny stocks to invest in now. In a report released on June 30, Swayampakula Ramakanth from H.C. Wainwright upgraded Vor Biopharma Inc. (NASDAQ:VOR) ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/07/25 | 2.29 | 2.32 | 2.15 | 2.21 | 3,649,877 |
29/07/25 | 2.46 | 2.65 | 2.30 | 2.35 | 6,536,700 |
28/07/25 | 2.235 | 2.56 | 2.235 | 2.42 | 9,566,767 |
25/07/25 | 2.18 | 2.21 | 2.03 | 2.20 | 3,080,861 |
24/07/25 | 2.14 | 2.27 | 2.12 | 2.17 | 3,435,129 |
23/07/25 | 2.06 | 2.22 | 2.06 | 2.09 | 5,507,800 |
22/07/25 | 2.07 | 2.12 | 1.97 | 2.05 | 3,547,000 |
21/07/25 | 2.275 | 2.31 | 1.98 | 2.05 | 5,778,000 |
18/07/25 | 2.36 | 2.49 | 2.20 | 2.21 | 7,119,400 |
17/07/25 | 2.15 | 2.65 | 2.149 | 2.38 | 12,230,700 |
|
|
||||
|
|
||||
|
|